Details for 2005855968

Up to date per 01.04.2026

Actions

Title / Product Name

GEZIELTE ABGABE VON BOTULINUMTOXIN ZUR BEHANDLUNG UND PRÄVENTION VON TRIGEMINALEN AUTONOMEN CEPHALGIEN, MIGRÄNE UND GEFÄSSERKRANKUNGEN

Status

Deleted

Protection Type

European Patent

(AT-) Application Number

2005855968

EP Publication Number

1846018

E-Number

676325

Language

PCT Number

US05047483

Publication Date

24.10.2007 A

09.07.2014 B1

Registration Date

09.07.2014

AT Publication Date

15.07.2014

Application Date

29.12.2005

Registration Number

Priorities

01.02.2005

593641 P

IPC

A61K 38/48 20060101AFI20090910BHEP

Maximum Duration of Protection

29.12.2025

Owner

ALLERGAN, INC.2525 Dupont Drive Irvine CA 92612US

Representative

No representatives present

Inventor

Blumenfeld, Andrew M.9850 GENESEE AVENUE, Suite 220 La Jolla, California 92037US